Apros Therapeutics
PrivateLast Round
Series A
Aug 1, 2016
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Apros Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in August 2016.
Apros Therapeutics is a biotechnology company that develops tissue-targeted small molecule innate immune agonists for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apros Therapeutics Comparables
Compare Apros Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 66% | |
| Eikon Therapeutics | 57% | |
| Inimmune | 55% |
For institutional investors. Book with your work email.
Apros Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 78% MoM, reaching 1.9K.
- Jul 25, 2026
Monthly visitors grew 691% MoM, from 162 to 1.3K.
For institutional investors. Book with your work email.
Apros Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apros Therapeutics's valuation, stock price, and market status.
Is Apros Therapeutics a public or private company?
Apros Therapeutics is a private company.
What is the current stock price of Apros Therapeutics?
Apros Therapeutics is a private company, so its shares have no public market price. Caplight tracks Apros Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apros Therapeutics worth (valuation)?
Valuation information for Apros Therapeutics is not publicly available.
Can I buy Apros Therapeutics stock?
Apros Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apros Therapeutics's last funding round?
Apros Therapeutics's most recent funding round was Series A on August 1, 2016.
Who are the main investors in Apros Therapeutics?
Investor information for Apros Therapeutics is not publicly disclosed.
Will Apros Therapeutics IPO soon?
No public IPO plans have been announced for Apros Therapeutics.
How can I track Apros Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Apros Therapeutics's shares on secondary markets.